Pathfinders in Biopharma

Perspectives from the cutting edge of biotech and pharma.

The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series.

Lead today. Define tomorrow.

Explore the Series

2021 Outlook: Pharma May be Ready to Deploy M&A Firepower

After a challenging year for M&A, Randall Stanicky, Managing Director and Specialty and Generic Pharmaceuticals Research Analyst at RBC Capital Markets, believes advancements in coronavirus vaccines, therapeutics, and biotech could fuel a resurgence in deal-making activity for the pharmaceutical sector in 2021.

5AM Ventures: Fueling the Next Generation of Innovators

In this episode of Pathfinders, Brian Abrahams, Managing Director and Co-Head of Biotechnology Equity Research at RBC Capital Markets speaks with Andy Schwab, Co-Founder and Managing Partner at 5AM Ventures.

Listen Now Read Article

Listen Time 19m Read Time 3m

Vida Ventures: Powering Breakthroughs in Biopharma

Luca Issi, Senior Biotechnology Research Analyst at RBC Capital Markets, discusses the art of building biopharma breakthroughs with Arjun Goyal, Co-Founder and Managing Director of Vida Ventures.

Listen Now Read Article

Listen Time 23m Read Time 3m

Biotech IPOs: Navigating the New Landscape

Even in a boom, biopharma executives will need to stay alert to the risks of undertaking an IPO. Our investment banking team discusses the right steps to take and pitfalls to avoid in today’s unique landscape.

Listen Now Read Article

Listen Time 20m Read Time 4m

Biotech IPOs: New Steps to Success on the Road to Going Public

In our launch edition of Pathfinders, our investment banking team looks at the best practices to follow on the road to IPO and the new predictive factors for success in today’s buoyant biopharma markets.

Listen Now Read Article

Listen Time 23m Read Time 3m

Subscribe to Future Episodes of Pathfinders

Our podcast series explores the fast-moving world of biopharma and what the road ahead looks like for companies and investors in the sector. Click here to subscribe to future episodes.

A Leading Partner for the Biopharma Industry

Our specialty expertise, combined with outstanding execution, has resulted in recurring transactions for biopharma clients as we partner with them through each stage of their development and growth.

At RBC Capital Markets, we believe organizations that lead today, define tomorrow. Our clients trust us to help them make the right decisions today and provide the perspective to innovate what’s next.

We take great care not to follow the latest trends, but thoughtfully analyze them. It’s never one opinion, but rather a trusted collective. Insights not just for the challenges clients face now, but for what’s on the horizon.

Recent Deals

In the ever-changing world of Biopharma, the right partners are paramount to spur investment in innovation and to scale growth. Our Biopharma team provides our clients with in-depth, industry-specific expertise, delivered through an integrated global investment banking practice.

About the Team

Connect with our Experts

More from RBC Capital Markets

Navigating the Changing Face of Healthcare

Healthcare is in the midst of a revolution. From the challenges facing individual sectors to breakthrough innovations, gain the insights you need into the forces that are reshaping the industry.

A Leader in Global Insights

Access market and industry insights, commentary and analysis from our expert team to gain the perspective you need to make the most informed decisions.

Subscribe Today

The latest in thought leadership, directly to your inbox.